Add-on Aripiprazole on Cardiometabolic Profile in Treatment Resistant Schizophrenia: RCT

Clinical trial NCT05766540 · UNKNOWN

Trial details

NCT number: NCT05766540
Sponsor: All India Institute of Medical Sciences, Bhubaneswar
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Difference in the Change in Cardiovascular Risk in Treatment Resistant Schizophrenia

Start date: 2023-08-20
Primary completion: 2023-11-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.